Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Endothelin A receptor antagonism by PD 156707 does not reduce infarct size after coronary artery occlusion/reperfusion in pigsT E Mertz, T B McClanahan, M A Flynn, et al.
Journal of Medicinal Chemistry|January 1, 1991
Synthesis and antiarrhythmic activity of cis-2,6-dimethyl-alpha,alpha-diaryl-1-piperidinebutanolsM L Hoefle, L T Blouin, R W Fleming, et al.
Journal of Thrombosis and Thrombolysis|December 21, 2000
The antithrombotic effects of CI-1028, an orally bioavailable direct thrombin inhibitor, in a canine model of venous and arterial thrombosisT B McClanahan, G W Hicks, D P Ignasiak, et al.
Journal of Medicinal Chemistry|January 1, 1991
Synthesis and antiarrhythmic activity of alpha-[(diarylmethoxy)methyl]-1-piperidineethanolsM L Hoefle, L T Blouin, R W Fleming, et al.
Journal of Thrombosis and Thrombolysis|March 15, 2001
Antithrombotic effect of LB-30057 (CI-1028), a new synthetic thrombin inhibitor, in a rabbit model of thrombosis: comparison with inogatranL Chi, T E Mertz, K L Rogers, et al.
Journal of Cardiovascular Pharmacology|June 1, 1995
Cardiac hypertrophy in rats after intravenous administration of CI-959, a novel antiinflammatory compound: morphologic features and pharmacokinetic and pharmacodynamic mechanismsJ E Low, A L Metz, T E Mertz, et al.
European Journal of Pharmacology|December 13, 2001
The antithrombotic effects of CI-1031 (ZK-807834) and enoxaparin in a canine electrolytic injury model of arterial and venous thrombosisT B McClanahan, G W Hicks, A L Morrison, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1986
CI-926 (3-[4-[4-(3-methylphenyl)-1-piperazinyl]butyl]-2,4-imidazolinedione): antihypertensive profile and pharmacologyM J Ryan, F A Bjork, D M Cohen, et al.
Journal of Medicinal Chemistry|March 1, 1986
Ribose-modified adenosine analogues as adenosine receptor agonistsM D Taylor, W H Moos, H W Hamilton, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1984
Antihypertensive effects of CI-907 (indolapril): a novel nonsulfhydryl angiotensin converting enzyme inhibitorM J Ryan, D M Boucher, D M Cohen, et al.
Pageof 3